{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:17:26Z","timestamp":1790727446320,"version":"4.1.0"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1001\/jamaophthalmol.2018.0806","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T12:30:40Z","timestamp":1524141040000},"page":"613","source":"Crossref","is-referenced-by-count":78,"title":["Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy"],"prefix":"10.1001","volume":"136","author":[{"given":"Giovanna","family":"Rotondo Dottore","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Torregrossa","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology, Pathology Unit, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Caturegli","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Immunology, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ionni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sframeli","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology, Ophthalmopathy Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sabini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Menconi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[{"name":"Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Sellari-Franceschini","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Nardi","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology, Ophthalmopathy Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Latrofa","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vitti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit II, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Basolo","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical and Molecular Pathology, Pathology Unit, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marin\u00f2","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"eoi180017r1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/thy.2014.0475","article-title":"Role of the underlying thyroid disease on the phenotype of Graves\u2019 orbitopathy in a tertiary referral center.","volume":"25","author":"Leo","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"eoi180017r2","first-page":"444","article-title":"Prevalence and natural history of Graves\u2019 orbitopathy in the XXI century.","volume":"36","author":"Piantanida","year":"2013","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"eoi180017r3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s40618-016-0516-7","article-title":"The phenotype of newly diagnosed Graves\u2019 disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.","volume":"39","author":"Bartalena","year":"2016","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"eoi180017r4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-00000025","article-title":"Current Insights into the pathogenesis of Graves\u2019 ophthalmopathy.","volume":"47","author":"Bahn","year":"2015","journal-title":"Horm Metab Res"},{"issue":"3","key":"eoi180017r5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","article-title":"Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease.","volume":"38","author":"Marin\u00f2","year":"2015","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"eoi180017r6","first-page":"1120","article-title":"Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves\u2019 ophthalmopathy.","volume":"77","author":"de Carli","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"eoi180017r7","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves\u2019 ophthalmopathy.","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"eoi180017r8","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/EJE-16-0552","article-title":"Management of endocrine disease: rituximab therapy for Graves\u2019 orbitopathy\u2014lessons from randomized control trials.","volume":"176","author":"Stan","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"115","key":"eoi180017r9","first-page":"213","article-title":"B cell\u2013targeted immunotherapy for type 1 diabetes: what can make it work?","volume":"21","author":"Hamad","year":"2016","journal-title":"Discov Med"},{"issue":"11","key":"eoi180017r10","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes.","volume":"63","author":"Arif","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"eoi180017r11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy guidelines for the management of Graves\u2019 orbitopathy.","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"9","key":"eoi180017r13","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease.","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"eoi180017r14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"eoi180017r15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40618-015-0255-1","article-title":"Total thyroid ablation in Graves\u2019 orbitopathy.","volume":"38","author":"Menconi","year":"2015","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"eoi180017r16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/cei.2017.189.issue-3","article-title":"Prevalence and clinical relevance of thyroid stimulating hormone receptor\u2013blocking antibodies in autoimmune thyroid disease.","volume":"189","author":"Diana","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"eoi180017r17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves disease: a global overview.","volume":"9","author":"Bartalena","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"eoi180017r18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40618-017-0608-z","article-title":"Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves\u2019 orbitopathy?","volume":"40","author":"Bartalena","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"eoi180017r19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2249.1998.00613.x","article-title":"Analysis of orbital T cells in thyroid-associated ophthalmopathy.","volume":"112","author":"F\u00f6rster","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"eoi180017r20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/bjo.2003.035915","article-title":"Thyroid associated ophthalmopathy: evidence for CD4+ ?d T cells; de novo differentiation of RFD7+ macrophages, but not of RFD1+ dendritic cells; and loss of ?d and a\u00df T cell receptor expression.","volume":"88","author":"Eckstein","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi180017r21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/bjo.84.5.517","article-title":"T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy.","volume":"84","author":"Pappa","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"eoi180017r22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/thy.2013.0240","article-title":"Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited.","volume":"24","author":"Menconi","year":"2014","journal-title":"Thyroid"},{"issue":"1","key":"eoi180017r23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/archopthalmol.2011.1215","article-title":"Small dose of rituximab for Graves orbitopathy: new insights into the mechanism of action.","volume":"130","author":"Salvi","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"eoi180017r12","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-009-5897-5","volume-title":"Finite Mixture Distributions","author":"Everitt","year":"1981"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2677668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T12:32:00Z","timestamp":1528979520000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.0806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.0806","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}